Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

794.2000 11.90 (1.52%)

NSE Jun 09, 2025 15:31 PM

52.59% Fall from 52W High

Volume: 382.0K

Strides Pharma Science Ltd.

06 Sep 2024

794.20

1.52%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300mg and 450mg

More from Strides Pharma Science Ltd.

Recommended

IPOs This Week: Ganga Bath Fittings set to list; Oswal Pumps and Four New Issues

| 09 Jun 2025, 03:55PM

Market closes higher, Bank of Baroda cuts lending rate by 50 bps to 8.15%

Trendlyne Marketwatch | 09 Jun 2025, 03:54PM

Earnings Call Transcript - Q1FY21 for Strides Pharma Science